Tag: VXRT stock

Business

Vaxart Inc (NASDAQ: VXRT) Continues To Be Hot This Week?

Vaxart Inc (NASDAQ:VXRT) traded at $0.56 at close of the session on Monday, June 23 and made a downward move of -3.38%% on its previous day’s price. Vaxart Inc has a market cap of $127.95 million and is expected to release its quarterly earnings report

Finance

Vaxart Inc (NASDAQ: VXRT): Overvalued In Comparison To Others?

Vaxart Inc (NASDAQ:VXRT) shares, rose in value on Wednesday, June 18, with the stock price up by 3.07% to the previous day’s close as strong demand from buyers drove the stock to $0.61. Actively observing the price movement in the last trading, the stock closed

Business

Vaxart Inc (NASDAQ: VXRT): Forecast Weak In 2025, Up -8.77%

The trading price of Vaxart Inc (NASDAQ:VXRT) closed higher on Friday, June 13, and closing at $0.70, 30.73% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.4901 and $0.779. In examining the 52-week

Companies

A New Perspective On Vaxart Inc (VXRT)

Vaxart Inc (NASDAQ:VXRT) concluded the trading at $0.40 on current market day with a fall of -2.10% from its closing price on previous day. Considering stock’s 52-week price range provides that VXRT hit a high price of $1.07 and saw its price falling to a

Companies

Vaxart Inc (NASDAQ: VXRT) Dropped -2.36%, But Don’t Panic

Vaxart Inc (NASDAQ:VXRT) shares, rose in value, with the stock price down by -2.36% to the previous day’s close as strong demand from buyers drove the stock to $0.45. Actively observing the price movement in the last trading, the stock closed the session at $0.46.

Companies

Analysts Offer Valuable Insight On Vaxart Inc (VXRT)

Vaxart Inc (NASDAQ:VXRT) price on Friday, May 23, fall -1.38% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.46. A look at the stock’s price movement, the close in the last trading session was $0.47. Turning to

NNOX Stock
Market Summary

Why shares of Vaxart Inc. (VXRT) are rising in premarket trading?

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.